Stock PHBI PHARMAGREEN BIOTECH INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Pharmagreen Biotech Inc. OTC Markets

Equities

PHBI

US00922N1046

Biotechnology & Medical Research

Delayed OTC Markets
Other stock markets
 11:11:07 2021-10-05 am EDT 		5-day change 1st Jan Change
0.0289 USD -.--% Intraday chart for Pharmagreen Biotech Inc. -4.87% +172.64%
Feb. 21 Pharmagreen Biotech Inc. Reports Earnings Results for the First Quarter Ended December 31, 2023 CI
Jan. 09 Pharmagreen Biotech Inc. Reports Earnings Results for the Full Year Ended September 30, 2023 CI

Valuation

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Capitalization 1 59.74 149.3 7.665 10.48 4.423 0.4014
Enterprise Value (EV) 1 60.52 149.4 8.367 10.73 4.753 0.773
P/E ratio -67 x -193 x -2.69 x -1.78 x -4.61 x -0.57 x
Yield - - - - - -
Capitalization / Revenue - - - - - 133,896,598 x
EV / Revenue - - - - - 257,842,228 x
EV / EBITDA - - - - - -
EV / FCF -106 x -164 x 13.6 x -10.5 x -27.3 x 4.39 x
FCF Yield -0.94% -0.61% 7.33% -9.5% -3.67% 22.8%
Price to Book -150 x -182 x -2.65 x -6.37 x -2.49 x -0.19 x
Nbr of stocks (in thousands) 20,600 74,672 95,806 381,171 442,261 573,461
Reference price 2 2.900 2.000 0.0800 0.0275 0.0100 0.000700
Announcement Date 3/20/19 12/27/19 1/8/21 12/29/21 1/17/23 1/9/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net sales - - - - - 0.002998
EBITDA - - - - - -
EBIT 1 -0.6698 -0.7737 -0.4857 -0.7527 -1.07 -0.474
Operating Margin - - - - - -15,810.84%
Earnings before Tax (EBT) 1 -0.7421 -0.7688 -2.483 -4.532 -0.8755 -0.5688
Net income 1 -1.074 -0.7675 -2.438 -4.532 -0.8755 -0.5688
Net margin - - - - - -18,971.81%
EPS 2 -0.0433 -0.0104 -0.0297 -0.0154 -0.002168 -0.001219
Free Cash Flow 1 -0.5687 -0.9135 0.6137 -1.019 -0.1743 0.1762
FCF margin - - - - - 5,878.02%
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 3/20/19 12/27/19 1/8/21 12/29/21 1/17/23 1/9/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: September 2018 2019 2020 2021 2022 2023
Net Debt 1 0.78 0.01 0.7 0.24 0.33 0.37
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 -0.57 -0.91 0.61 -1.02 -0.17 0.18
ROE (net income / shareholders' equity) 39.2% 69.2% 132% 196% 49.8% 28.4%
ROA (Net income/ Total Assets) -90.5% -89.6% -67.7% -147% -230% -179%
Assets 1 1.186 0.8569 3.6 3.079 0.3811 0.3173
Book Value Per Share 2 -0.0200 -0.0100 -0.0300 -0 -0 -0
Cash Flow per Share 2 0 0 0 0 0 0
Capex 1 0.25 0.2 - - - -
Capex / Sales - - - - - -
Announcement Date 3/20/19 12/27/19 1/8/21 12/29/21 1/17/23 1/9/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+1.51% 42.75B
MODERNA, INC. Stock Moderna, Inc.
+8.57% 41.34B
LONZA GROUP AG Stock Lonza Group AG
+49.22% 41.61B
CELLTRION, INC. Stock Celltrion, Inc.
-12.36% 26.59B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+8.92% 25.49B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-25.13% 18.12B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.17% 12.24B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-3.12% 11.76B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+6.35% 11B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. PHBI Stock
  4. PHBI Stock
  5. Financials Pharmagreen Biotech Inc.